Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to HER2-negative Breast Cancer
Related studies linked through entity extraction aliases.
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib
- Status
- RECRUITING
- Phase
- PHASE2
Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment
- Status
- RECRUITING
- Phase
- PHASE3
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of the TheraBionic P1 Device in Breast Cancer
- Status
- RECRUITING
- Phase
- NA
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Status
- RECRUITING
- Phase
- PHASE1
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Breast Re-irradiation After Second Ipsilateral Lumpectomy
- Status
- RECRUITING
- Phase
- NA
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
NearWave Optical Molecular Monitoring
- Status
- RECRUITING
- Phase
- NA
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- N/A